Upcoming Workshops
Past Workshops
- Acute Myelogenous Leukemia (AML): Current Treatment Perspectives
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- What’s New In Precision Medicine
- Chronic Lymphocytic Leukemia (CLL): Treatment Updates
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Progress in the Treatment of Myelodysplastic Syndromes (MDS)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Acute Myeloid Leukemia (AML): Treatment Updates
- Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia: What's NewPart I of Living with Chronic Lymphocytic Leukemia
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Myelofibrosis
- Update on the Treatment of Acute Myelogenous Leukemia (AML)
- Coping with the Stresses of Caregiving When Your Loved One Has Chronic Lymphocytic Leukemia (CLL)
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
- Progress in the Treatment of Myelodysplastic Syndromes (MDS)
- Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)Part II of Living with Chronic Lymphocytic Leukemia (CLL)
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia (CLL)
- Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart II of Your Guide to the Latest Cancer Research and Treatment
- Living with Acute Myelogenous Leukemia (AML)
- Progress in the Treatment of Myelodysplastic Syndrome (MDS)
- Living with Chronic Myelogenous Leukemia (CML)
- Coping with the Stresses of Caregiving When Your Loved One Has Chronic Lymphocytic Leukemia (CLL)
- Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Life with Chronic Lymphocytic Leukemia (CLL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update on Chronic Lymphocytic LeukemiaPart I of Life with Chronic Lymphocytic Leukemia (CLL)
- Taking Your Blood Cancer Treatment on Schedule
- Updates in the Treatment of Acute Myelogenous Leukemia
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
- Life with CLL: Taking Charge of Your Treatment SchedulePart II of Life with Chronic Lymphocytic Leukemia (CLL)
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
- The Role of Exercise, Meditation and NutritionPart III of Living with Myeloproliferative Neoplasms (MPN)
- I Can’t Remember to Take My Pills on Time: Help! A Practical Guide to FollowPart III of Going the Distance: Thriving and Surviving with Chronic Myelogenous Leukemia (CML)